The NMPA registration process in China is highly focused on compliance verification to ensure that medical devices meet Chinese standards for safety, quality, and efficacy. Manufacturers must comply with local regulations, international standards, and specific NMPA requirements regarding manufacturing practices, clinical trial data, product performance, labeling, and post-market surveillance. Compliance verification is carried out through documentation review, facility inspections, product testing, clinical evaluations, and third-party audits to confirm that the device can be safely marketed in China.